Monitor for any future conversion to SC 13D or increased activism, though T. Rowe Price is a traditional passive asset manager. The 16.6% stake is large for a passive filer — watch for any subsequent filings that could signal a change in intent or further accumulation.
Price Chart
Executive Summary
T. Rowe Price Associates, Inc. filed a Schedule 13G disclosing a 16.6% passive stake in Beta Bionics, Inc. as of September 30, 2026. This is a new filing by T. Rowe Price, indicating a significant institutional position in the medical device company, though the filing explicitly disclaims any intent to influence control.
Key Financial Metrics
Key Facts
- T. Rowe Price Associates, Inc. filed a new Schedule 13G for Beta Bionics, Inc.
- Stake: 8,943,061 shares of common stock, representing 16.6% of shares outstanding.
- Filing date: October 7, 2026, with ownership as of September 30, 2026.
- T. Rowe Price Health Sciences Fund holds 2,408,699 shares (5.4% of class) within this position.
- Filer certifies passive intent under Rule 13d-1(b) — no intent to influence control.
Financial Impact
16.6% passive stake valued at undisclosed amount (no price per share provided in filing).
Risk Factors
- Passive filing — no indication of activist intent, but large stake could attract attention from activists or potential acquirers.
- T. Rowe Price could reduce position without further disclosure until below 5% threshold.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000080255-26-000609 |
| Document: 0000080255-26-000609-index.html | 0000080255-26-000609 |
| Document: 0000080255-26-000609.txt | 0000080255-26-000609 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | SC 13G | $18.08 | awaiting T+20 | — | $20.51 (+13.44%) |
Sep 23, 2026 4w ago | Insider Cluster | $21.76 $19.34 | ▲ +11.12% | ▲ +10.70% | $20.51 (+5.74%) |
Sep 18, 2026 5w ago | Insider Cluster | $22.04 $16.84 | ▲ +23.59% | ▲ +22.69% | $20.51 (+6.94%) |
Sep 17, 2026 5w ago | Press Release | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $20.51 (−6.30%) |
Sep 17, 2026 5w ago | Insider Cluster | $21.89 $16.35 | ▼ −25.31% | ▼ −25.51% | $20.51 (−6.30%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $20.51 (+7.53%) |
Sep 15, 2026 5w ago | 8-K | $22.18 $16.87 | ▼ −23.94% | ▼ −26.00% | $20.51 (−7.53%) |
Sep 15, 2026 5w ago | Press Release | $22.18 $16.87 | ▲ +23.94% | ▲ +26.00% | $20.51 (+7.53%) |
Sep 14, 2026 6w ago | Press Release | $16.73 $17.86 | ▲ +6.75% | ▲ +4.49% | $20.51 (+22.59%) |
Sep 10, 2026 6w ago | Insider Cluster | $16.57 $17.63 | ▼ −6.40% | ▼ −4.53% | $20.51 (−23.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers